Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01F
- Chemical subgroupJ01FA
- Chemical substanceJ01FA09Clarithromycin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 75 registrations
Show all 75Canada
Health Canada · 47 registrations
- Apo-Clarithromycin250 MG · Tablet · Apotex INC
- Apo-Clarithromycin500 MG · Tablet · Apotex INC
- Apo-Clarithromycin XL500 MG · Tablet (Extended-Release) · Apotex INC
- Biaxin125 MG / 5 ML · Granules For Suspension · BGP Pharma Ulc
At a glance
- ATC code
- J01FA09
- ATC group
- Anti-infectives for systemic use
- Registers
- 9
- Historical lists
- 2
- Registrations
- 301
- With their own page
- 162
- Companies
- 136
All medicines with Clarithromycin
Human medicines from every register that match Clarithromycin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
302 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Clarithromycin | United States | 1GM, 500MG | tablet, extended release | Marketed | Sunshine |
| Clarithromycin | United States | 125MG/5ML, 250MG/5ML | for suspension | Marketed | Sandoz |
| Clarithromycin | United States | 250MG, 500MG | tablet | Marketed | Teva |
| Clarithromycin | Canada | 500 MG | Tablet | Marketed | Sanis Health INC |
| Clarithromycin | Canada | 250 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Clarithromycin | Canada | 500 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Clarithromycin | Canada | 250 MG | Tablet | Marketed | Sanis Health INC |
| Clarithromycin | Canada | 125 MG / 5 ML | Granules For Suspension | Not marketed | Sanis Health INC |
| Clarithromycin | Canada | 250 MG / 5 ML | Granules For Suspension | Not marketed | Sanis Health INC |
| M-Clarithromycin | Canada | 500 MG | Tablet | Marketed | Mantra Pharma INC |
| Apo-Clarithromycin | Canada | 500 MG | Tablet | Marketed | Apotex INC |
| Apo-Clarithromycin | Canada | 250 MG | Tablet | Marketed | Apotex INC |
| Pro-Clarithromycin | Canada | 500 MG | Tablet | Marketed | Pro Doc Limitee |
| Pro-Clarithromycin | Canada | 250 MG | Tablet | Marketed | Pro Doc Limitee |
| Taro-Clarithromycin | Canada | 500 MG | Tablet | Marketed | Sun Pharma Canada INC |
| Taro-Clarithromycin | Canada | 250 MG | Tablet | Marketed | Sun Pharma Canada INC |
| Taro-Clarithromycin | Canada | 250 MG / 5 ML | Powder For Suspension | Marketed | Taro Pharmaceuticals INC |
| Taro-Clarithromycin | Canada | 125 MG / 5 ML | Powder For Suspension | Marketed | Taro Pharmaceuticals INC |
| Ran-Clarithromycin | Canada | 250 MG / 5 ML | Powder For Suspension | Authorised | Sun Pharma Canada INC |
| Ran-Clarithromycin | Canada | 125 MG / 5 ML | Powder For Suspension | Authorised | Sun Pharma Canada INC |
| Apo-Clarithromycin XL | Canada | 500 MG | Tablet (Extended-Release) | Marketed | Apotex INC |
| Sandoz Clarithromycin | Canada | 250 MG | Tablet | Marketed | Sandoz Canada Incorporated |
| Sandoz Clarithromycin | Canada | 500 MG | Tablet | Marketed | Sandoz Canada Incorporated |
| Teva-Clarithromycin XL | Canada | 500 MG | Tablet (Extended-Release) | Marketed | Teva Canada Limited |
| PMS-Clarithromycin | Canada | 250 MG | Tablet | Not marketed | Pharmascience INC |